Wayne Hummer Investments L.L.C. purchased a new position in Aetna Inc. (NYSE:AET) during the first quarter, Holdings Channel reports. The firm purchased 6,980 shares of the company’s stock, valued at approximately $890,000.

A number of other hedge funds have also made changes to their positions in the company. Ibex Wealth Advisors increased its position in Aetna by 3.5% in the fourth quarter. Ibex Wealth Advisors now owns 15,651 shares of the company’s stock worth $1,918,000 after buying an additional 526 shares during the period. Davis Selected Advisers increased its position in Aetna by 161.7% in the fourth quarter. Davis Selected Advisers now owns 3,937,198 shares of the company’s stock worth $488,252,000 after buying an additional 2,432,885 shares during the period. Pacad Investment Ltd. increased its position in Aetna by 1,160.0% in the fourth quarter. Pacad Investment Ltd. now owns 36,516 shares of the company’s stock worth $4,528,000 after buying an additional 33,618 shares during the period. Capital Guardian Trust Co. increased its position in Aetna by 6.2% in the fourth quarter. Capital Guardian Trust Co. now owns 698,165 shares of the company’s stock worth $86,579,000 after buying an additional 40,712 shares during the period. Finally, Columbus Circle Investors increased its position in Aetna by 358.8% in the first quarter. Columbus Circle Investors now owns 51,831 shares of the company’s stock worth $6,611,000 after buying an additional 40,535 shares during the period. 91.91% of the stock is owned by institutional investors.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Aetna Inc. (NYSE:AET) opened at 150.59 on Friday. The stock has a market capitalization of $49.95 billion, a PE ratio of 45.93 and a beta of 0.48. Aetna Inc. has a 12 month low of $104.59 and a 12 month high of $150.99. The firm has a 50-day moving average price of $144.12 and a 200 day moving average price of $131.19.

Aetna (NYSE:AET) last issued its earnings results on Tuesday, May 2nd. The company reported $2.71 EPS for the quarter, topping analysts’ consensus estimates of $2.36 by $0.35. Aetna had a return on equity of 17.75% and a net margin of 1.84%. The firm had revenue of $15.17 billion for the quarter, compared to the consensus estimate of $15.39 billion. During the same quarter in the prior year, the business earned $2.30 earnings per share. The company’s revenue was down 3.4% compared to the same quarter last year. Equities analysts anticipate that Aetna Inc. will post $8.99 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, July 28th. Stockholders of record on Thursday, July 13th will be paid a $0.50 dividend. The ex-dividend date is Tuesday, July 11th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.33%. Aetna’s payout ratio is 62.31%.

TRADEMARK VIOLATION WARNING: “Wayne Hummer Investments L.L.C. Purchases Shares of 6,980 Aetna Inc. (AET)” was originally published by Financial Market News and is the property of of Financial Market News. If you are viewing this news story on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The legal version of this news story can be accessed at https://www.financial-market-news.com/2017/06/17/wayne-hummer-investments-l-l-c-purchases-shares-of-6980-aetna-inc-aet.html.

A number of equities analysts have issued reports on the company. Royal Bank Of Canada increased their price objective on Aetna from $147.00 to $162.00 and gave the stock an “outperform” rating in a report on Friday, June 9th. Morgan Stanley assumed coverage on Aetna in a report on Tuesday, June 6th. They issued an “overweight” rating and a $162.00 price objective for the company. ValuEngine upgraded Aetna from a “hold” rating to a “buy” rating in a report on Friday, June 2nd. Argus reiterated a “buy” rating and issued a $165.00 price objective (up previously from $145.00) on shares of Aetna in a report on Tuesday, May 30th. Finally, Cowen and Company set a $170.00 price objective on Aetna and gave the stock a “buy” rating in a report on Saturday, May 27th. Eight equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $147.99.

In other news, insider Shawn M. Guertin sold 29,602 shares of the company’s stock in a transaction dated Thursday, March 23rd. The stock was sold at an average price of $129.35, for a total value of $3,829,018.70. Following the sale, the insider now owns 44,880 shares in the company, valued at $5,805,228. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Margaret M. Mccarthy sold 27,028 shares of the company’s stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total value of $4,033,388.44. Following the completion of the sale, the executive vice president now owns 33,563 shares in the company, valued at approximately $5,008,606.49. The disclosure for this sale can be found here. Insiders sold 160,177 shares of company stock worth $22,440,789 in the last 90 days. Company insiders own 0.90% of the company’s stock.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.